Skip to main content
Premium Trial:

Request an Annual Quote

Compugen Begins Shipping New BioXL Analysis Computer

Premium

PETACH-TIKVA, Israel--Compugen here has begun shipping BioXL, its newest high-end sequence analysis computer system designed for target discovery. The scalable system includes proprietary components on both the hardware and the software side. "With BioXL's superior functionality, algorithmic range, and computational power that scales to more than 50-gig matrix cell updates per second, our clients can now enjoy the ultimate solution for sequence data mining," claimed Meir Yedidia, Compugen's marketing manager of sequence analysis products.

Compugen develops proprietary bioinformatics technologies and markets them to pharmaceutical and genomics companies for use in analyzing genomic and protein sequence data and discovering of new drug leads. The company has satellite offices in Woburn, Mass., and Japan.

Filed under

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.